October 22, 20194G Clinical Selected for its Utilization of Natural Language Processing to Turn Study Parameters into Detailed Forecasts
4G Clinical’s forecasting engine, which is fully integrated with its Randomization and Trial Supply Management (RTSM) system, provides a dynamic and transparent capability for clinical supply professionals.
“Recognizing the need for innovation beyond site and depot forecasting, the innovation utilizes NLP to turn study parameters from plain English into detailed forecasts. This demand-driven solution has addressed the formidable challenge of drug development to achieve greater efficacy,” states BSMA Executive Director, Devendra Mishra.
“Clinical trials today can have unpredictable enrollment and study design changes which increases supply chain complexity,” says Jan Pieter Kappelle, Vice President, Strategy, 4G Clinical. “Clinical supply planners should be able to modify supply models as frequently as needed without effort, with full transparency into inputs and a direct correlation to its outputs. We are honored to be receive this prestigious award.”
For more information on 4G Clinical’s solutions, visit www.4gclinical.com.
About 4G Clinical
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. Learn more at www.4gclinical.com.
Since its inception in 2007, BSMA is a global organization that fosters Innovation and Adoption of disruptive technologies within the end-to-end supply chain of the Life Sciences industry. With offices in California (USA), Brussels (Belgium) and Mumbai (India), BSMA promotes collaboration and networking between professionals of the biotech, pharmaceutical, academic and medical diagnostics enterprises. The Alliance partners with industry, academia, foundations, suppliers, technology enablers, research institutions, trade organizations and the government to improve productivity, quality, product and service integrity, risk mitigation, managerial talent development and patient care globally. It is also the home of start-up companies engaged in business development and scale up. Learn more at www.biosupplyalliance.com.
To see the full release, click here.
370 Washington Street
Wellesley, MA 02481